Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines.

Borges MB, Marchevsky RS, Carvalho Pereira R, da Silva Mendes Y, Almeida Mendes LG, Diniz-Mendes L, Cruz MA, Tahmaoui O, Baudart S, Freire M, Homma A, Schneider-Ohrum K, Vaughn DW, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L.

PLoS Pathog. 2019 Apr 22;15(4):e1007721. doi: 10.1371/journal.ppat.1007721. eCollection 2019 Apr.

2.

Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques.

Borges MB, Marchevsky RS, Mendes YS, Mendes LG, Duarte AC, Cruz M, de Filippis AMB, Vasconcelos PFC, Freire M, Homma A, Mossman S, Lepine E, Vanloubbeeck Y, Lorin C, Malice MP, Caride E, Warter L.

PLoS One. 2018 Apr 25;13(4):e0196311. doi: 10.1371/journal.pone.0196311. eCollection 2018.

3.

Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.

Marnata C, Saulnier A, Mompelat D, Krey T, Cohen L, Boukadida C, Warter L, Fresquet J, Vasiliauskaite I, Escriou N, Cosset FL, Rey FA, Lanford RE, Karayiannis P, Rose NJ, Lavillette D, Martin A.

J Virol. 2015 Dec;89(23):12131-44. doi: 10.1128/JVI.01161-15. Epub 2015 Sep 23.

4.

An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaques.

Fernandez S, Thomas SJ, De La Barrera R, Im-Erbsin R, Jarman RG, Baras B, Toussaint JF, Mossman S, Innis BL, Schmidt A, Malice MP, Festraets P, Warter L, Putnak JR, Eckels KH.

Am J Trop Med Hyg. 2015 Apr;92(4):698-708. doi: 10.4269/ajtmh.14-0268. Epub 2015 Feb 2.

5.

Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.

Xu M, Hadinoto V, Appanna R, Joensson K, Toh YX, Balakrishnan T, Ong SH, Warter L, Leo YS, Wang CI, Fink K.

J Immunol. 2012 Dec 15;189(12):5877-85. doi: 10.4049/jimmunol.1201688. Epub 2012 Nov 14.

6.

Use of human monoclonal antibodies to treat Chikungunya virus infection.

Fric J, Bertin-Maghit S, Wang CI, Nardin A, Warter L.

J Infect Dis. 2013 Jan 15;207(2):319-22. doi: 10.1093/infdis/jis674. Epub 2012 Nov 2.

PMID:
23125446
7.

Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology.

Warter L, Appanna R, Fink K.

Immunol Res. 2012 Sep;53(1-3):148-61. doi: 10.1007/s12026-012-8268-8. Review.

PMID:
22434513
8.

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants.

Lee CY, Kam YW, Fric J, Malleret B, Koh EG, Prakash C, Huang W, Lee WW, Lin C, Lin RT, Renia L, Wang CI, Ng LF, Warter L.

PLoS Pathog. 2011 Dec;7(12):e1002390. doi: 10.1371/journal.ppat.1002390. Epub 2011 Dec 1.

9.

A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax.

Russell B, Suwanarusk R, Borlon C, Costa FT, Chu CS, Rijken MJ, Sriprawat K, Warter L, Koh EG, Malleret B, Colin Y, Bertrand O, Adams JH, D'Alessandro U, Snounou G, Nosten F, Rénia L.

Blood. 2011 Sep 29;118(13):e74-81. doi: 10.1182/blood-2011-04-348748. Epub 2011 Jul 18.

10.

Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.

Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Desprès P, Wang CI, Nardin A.

J Immunol. 2011 Mar 1;186(5):3258-64. doi: 10.4049/jimmunol.1003139. Epub 2011 Jan 28.

11.

A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication.

Benureau Y, Warter L, Malcolm BA, Martin A.

Virology. 2010 Oct 25;406(2):228-40. doi: 10.1016/j.virol.2010.07.014. Epub 2010 Aug 11.

12.

A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.

Warter L, Cohen L, Benureau Y, Chavez D, Yang Y, Bodola F, Lemon SM, Traboni C, Lanford RE, Martin A.

PLoS One. 2009;4(2):e4419. doi: 10.1371/journal.pone.0004419. Epub 2009 Feb 10.

13.

A comparative cell biological analysis reveals only limited functional homology between the NS5A proteins of hepatitis C virus and GB virus B.

Mankouri J, Milward A, Pryde KR, Warter L, Martin A, Harris M.

J Gen Virol. 2008 Aug;89(Pt 8):1911-20. doi: 10.1099/vir.0.2008/001131-0.

PMID:
18632962
14.

GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS.

Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, Warter L, Lanford RE, Weinman SA, Lemon SM, Martin A, Li K.

J Virol. 2007 Jan;81(2):964-76. Epub 2006 Nov 8.

Supplemental Content

Loading ...
Support Center